Biotech, Deals, Partnering

EPIRUS and Orygen are biotech partnering for BOW015

Posted on 23 October 2013

Tags: , ,

EPIRUS and Orygen Biotecnologia announced a broad biotech partnering collaboration for the development, manufacture and commercialization of multiple biotechnology products in Brazil.

EPIRUS and ORYGEN will pursue the registration of BOW015, the EPIRUS biosimilar molecule to REMICADE, with Brazil’s National Agency of Sanitary Surveillance.

EPIRUS will also transfer BOW015 technology to ORYGEN to facilitate manufacturing in Brazil.

EPIRUS recently announced successful Phase 3 data for BOW015.

EPIRUS and ORYGEN have also agreed to develop additional biotechnology products for manufacture and commercialization in Brazil to continue this biotech partnering .

For BOW015 and each of these additional assets, ORYGEN will hold exclusive rights in Brazil, and EPIRUS will maintain exclusive global rights for all markets outside of Brazil.

EPIRUS will also transfer to ORYGEN its proprietary bio-manufacturing system, SCALE™, which will enable In Market, For Market™ production of BOW015 and the rest of the EPIRUS pipeline.

Under the terms of the agreement, ORYGEN will invest in the construction of a manufacturing facility, the transfer of product and manufacturing technology from EPIRUS to ORYGEN and the clinical development of the EPIRUS pipeline.

EPIRUS will earn up to $275 million in upfront, milestone, and royalty payments and service-based fees.

For further deal information visit Current Agreements (subscription required)

Related

Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

 

Print Friendly, PDF & Email

Leave a Reply

 

cpbannerad300x150new1gif
rauconbadgejpg
e80banner300x150animgif
cpbannerad300x150new2gif
rauconbadgejpg
a1banner300x150animgif